If fibrinolytics are used, the dose once again is 100 mg administered intravenously over 2 hours. Of note, there does not seem to be a difference in outcome in terms of the rapidity in which the ...

Because of their ease of administration, bolus fibrinolytic therapy is likely to be a key component of contemporary reperfusion regimens for the treatment of acute myocardial infarction, and ...

Of the fibrinolytics, tenecteplase (TNKase; Genentech) is a rapid-onset, single-bolus, plasminogen activator that is easy to deliver, said Samady. Alteplase (Activase; Genentech), which is infused ...